285 related articles for article (PubMed ID: 17015625)
1. Functional analysis of DNA gyrase mutant enzymes carrying mutations at position 88 in the A subunit found in clinical strains of Mycobacterium tuberculosis resistant to fluoroquinolones.
Matrat S; Veziris N; Mayer C; Jarlier V; Truffot-Pernot C; Camuset J; Bouvet E; Cambau E; Aubry A
Antimicrob Agents Chemother; 2006 Dec; 50(12):4170-3. PubMed ID: 17015625
[TBL] [Abstract][Full Text] [Related]
2. Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes.
Aubry A; Veziris N; Cambau E; Truffot-Pernot C; Jarlier V; Fisher LM
Antimicrob Agents Chemother; 2006 Jan; 50(1):104-12. PubMed ID: 16377674
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China.
Zhu C; Zhang Y; Shen Y; Siu GK; Wu W; Qian X; Deng G; Xu Y; Lau R; Fan X; Zhang W; Lu H; Yam WC
Diagn Microbiol Infect Dis; 2012 Jul; 73(3):260-3. PubMed ID: 22560167
[TBL] [Abstract][Full Text] [Related]
4. Sensitivities of ciprofloxacin-resistant Mycobacterium tuberculosis clinical isolates to fluoroquinolones: role of mutant DNA gyrase subunits in drug resistance.
Suzuki Y; Nakajima C; Tamaru A; Kim H; Matsuba T; Saito H
Int J Antimicrob Agents; 2012 May; 39(5):435-9. PubMed ID: 22421328
[TBL] [Abstract][Full Text] [Related]
5. Role of gyrB Mutations in Pre-extensively and Extensively Drug-Resistant Tuberculosis in Thai Clinical Isolates.
Disratthakit A; Prammananan T; Tribuddharat C; Thaipisuttikul I; Doi N; Leechawengwongs M; Chaiprasert A
Antimicrob Agents Chemother; 2016 Sep; 60(9):5189-97. PubMed ID: 27297489
[TBL] [Abstract][Full Text] [Related]
6. gyrA/B fluoroquinolone resistance allele profiles amongst Mycobacterium tuberculosis isolates from mainland China.
Long Q; Li W; Du Q; Fu Y; Liang Q; Huang H; Xie J
Int J Antimicrob Agents; 2012 Jun; 39(6):486-9. PubMed ID: 22526012
[TBL] [Abstract][Full Text] [Related]
7. DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis.
Pantel A; Petrella S; Matrat S; Brossier F; Bastian S; Reitter D; Jarlier V; Mayer C; Aubry A
Antimicrob Agents Chemother; 2011 Oct; 55(10):4524-9. PubMed ID: 21768507
[TBL] [Abstract][Full Text] [Related]
8. Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of Mycobacterium tuberculosis H37Ra.
Kocagöz T; Hackbarth CJ; Unsal I; Rosenberg EY; Nikaido H; Chambers HF
Antimicrob Agents Chemother; 1996 Aug; 40(8):1768-74. PubMed ID: 8843279
[TBL] [Abstract][Full Text] [Related]
9. Multiplex allele-specific PCR combined with PCR-RFLP analysis for rapid detection of gyrA gene fluoroquinolone resistance mutations in Mycobacterium tuberculosis.
Zhao LL; Xia Q; Lin N; Liu ZG; Zhao XQ; Wan KL
J Microbiol Methods; 2012 Jan; 88(1):175-8. PubMed ID: 22115861
[TBL] [Abstract][Full Text] [Related]
10. Characteristic resistance mechanism of Mycobacterium tuberculosis to DC-159a, a new respiratory quinolone.
Sekiguchi J; Disratthakit A; Maeda S; Doi N
Antimicrob Agents Chemother; 2011 Aug; 55(8):3958-60. PubMed ID: 21555766
[TBL] [Abstract][Full Text] [Related]
11. Fluoroquinolone interactions with Mycobacterium tuberculosis gyrase: Enhancing drug activity against wild-type and resistant gyrase.
Aldred KJ; Blower TR; Kerns RJ; Berger JM; Osheroff N
Proc Natl Acad Sci U S A; 2016 Feb; 113(7):E839-46. PubMed ID: 26792518
[TBL] [Abstract][Full Text] [Related]
12. A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system.
Maruri F; Sterling TR; Kaiga AW; Blackman A; van der Heijden YF; Mayer C; Cambau E; Aubry A
J Antimicrob Chemother; 2012 Apr; 67(4):819-31. PubMed ID: 22279180
[TBL] [Abstract][Full Text] [Related]
13. Comparison of gyrA gene mutations between laboratory-selected ofloxacin-resistant Mycobacterium tuberculosis strains and clinical isolates.
Sun Z; Zhang J; Zhang X; Wang S; Zhang Y; Li C
Int J Antimicrob Agents; 2008 Feb; 31(2):115-21. PubMed ID: 18164184
[TBL] [Abstract][Full Text] [Related]
14. Docking studies on novel analogues of 8 methoxy fluoroquinolones against GyrA mutants of Mycobacterium tuberculosis.
Anand RS; Somasundaram S; Doble M; Paramasivan CN
BMC Struct Biol; 2011 Dec; 11():47. PubMed ID: 22152119
[TBL] [Abstract][Full Text] [Related]
15. Gyrase Mutations Are Associated with Variable Levels of Fluoroquinolone Resistance in Mycobacterium tuberculosis.
Farhat MR; Jacobson KR; Franke MF; Kaur D; Sloutsky A; Mitnick CD; Murray M
J Clin Microbiol; 2016 Mar; 54(3):727-33. PubMed ID: 26763957
[TBL] [Abstract][Full Text] [Related]
16. Influence of lineage-specific amino acid dimorphisms in GyrA on Mycobacterium tuberculosis resistance to fluoroquinolones.
Kim H; Nakajima C; Kim YU; Yokoyama K; Suzuki Y
Jpn J Infect Dis; 2012; 65(1):72-4. PubMed ID: 22274162
[TBL] [Abstract][Full Text] [Related]
17. The role of intra- and extragenic compensatory mutations in the suppression of fluoroquinolone resistance in a Salmonella Typhimurium gyrA mutant (D87G).
Preisler A; Heisig P
J Antimicrob Chemother; 2009 Feb; 63(2):290-4. PubMed ID: 19033246
[TBL] [Abstract][Full Text] [Related]
18. Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003.
Huang TS; Kunin CM; Shin-Jung Lee S; Chen YS; Tu HZ; Liu YC
J Antimicrob Chemother; 2005 Dec; 56(6):1058-62. PubMed ID: 16204341
[TBL] [Abstract][Full Text] [Related]
19. Characterization of gyrA and gyrB mutations associated with fluoroquinolone resistance in Mycobacterium tuberculosis isolates from Morocco.
Chaoui I; Oudghiri A; El Mzibri M
J Glob Antimicrob Resist; 2018 Mar; 12():171-174. PubMed ID: 29033301
[TBL] [Abstract][Full Text] [Related]
20. Characterization of gyrA and gyrB mutations and fluoroquinolone resistance in Mycobacterium tuberculosis clinical isolates from Hubei Province, China.
Chen J; Chen Z; Li Y; Xia W; Chen X; Chen T; Zhou L; Xu B; Xu S
Braz J Infect Dis; 2012; 16(2):136-41. PubMed ID: 22552454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
